{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:20:07Z","timestamp":1762507207085},"reference-count":40,"publisher":"Elsevier BV","issue":"42","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Polish State Committee for Scientific Research","award":["2 P04B 001 27"],"award-info":[{"award-number":["2 P04B 001 27"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.vaccine.2017.07.082","type":"journal-article","created":{"date-parts":[[2017,9,14]],"date-time":"2017-09-14T03:00:11Z","timestamp":1505358011000},"page":"5714-5721","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["HBcAg produced in transgenic tobacco triggers Th1 and Th2 response when intramuscularly delivered"],"prefix":"10.1016","volume":"35","author":[{"given":"Marcin","family":"Pyrski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Rugowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamil Robert","family":"Wierzbi\u0144ski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Kasprzyk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Bogusiewicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piotr","family":"Boci\u0105g","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u0142awomir","family":"Samardakiewicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcin","family":"Czy\u017c","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maciej","family":"Kurpisz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomasz","family":"Pniewski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2017.07.082_b0005","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.virusres.2004.08.016","article-title":"Envelopment of the hepatitis B virus nucleocapsid","volume":"106","author":"Bruss","year":"2004","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2017.07.082_b0010","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1146\/annurev.iy.13.040195.000333","article-title":"Hepatitis B virus immunopathogenesis","volume":"13","author":"Chisari","year":"1995","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.vaccine.2017.07.082_b0015","first-page":"29","article-title":"HBcAg induced T-cell independent anti-HBc production in chronic HBsAg carriers, Springer","author":"Sylvan","year":"1992","journal-title":"Vienna"},{"key":"10.1016\/j.vaccine.2017.07.082_b0020","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.pep.2010.09.010","article-title":"Highly efficient production of phosphorylated hepatitis B core particles in yeast Pichia pastoris","volume":"75","author":"Freivalds","year":"2011","journal-title":"Protein Expr Purif"},{"key":"10.1016\/j.vaccine.2017.07.082_b0025","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.patbio.2010.01.006","article-title":"Hepatitis B vaccines: protective efficacy and therapeutic potential","volume":"58","author":"Michel","year":"2010","journal-title":"Pathol Biol"},{"key":"10.1016\/j.vaccine.2017.07.082_b0030","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1128\/CVI.00468-09","article-title":"Construction and immunological evaluation of multivalent hepatitis B virus (HBV) core virus-like particles carrying HBV and HCV epitopes","volume":"17","author":"Sominskaya","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2017.07.082_b0035","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1073\/pnas.96.5.1915","article-title":"Native display of complete foreign protein domains on the surface of hepatitis B virus capsids","volume":"96","author":"Kratz","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2017.07.082_b0040","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1586\/erv.12.150","article-title":"Hepatitis B core\u2013based virus\u2013like particles to present heterologous epitopes","volume":"12","author":"Roose","year":"2013","journal-title":"Expert Rev Vacc"},{"key":"10.1016\/j.vaccine.2017.07.082_b0045","doi-asserted-by":"crossref","first-page":"12950","DOI":"10.1128\/JVI.77.24.12950-12960.2003","article-title":"Stability and morphology comparisons of self-assembled virus-like particles from wild-type and mutant human hepatitis B virus capsid proteins","volume":"77","author":"Newman","year":"2003","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2017.07.082_b0050","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jviromet.2005.06.020","article-title":"The use of viral vectors to produce hepatitis B virus core particles in plants","volume":"131","author":"Mechtcheriakova","year":"2006","journal-title":"J Virol Meth"},{"key":"10.1016\/j.vaccine.2017.07.082_b0055","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1104\/pp.108.126284","article-title":"Extremely high-level and rapid transient protein production in plants without the use of viral replication","volume":"148","author":"Sainsbury","year":"2008","journal-title":"Plant Physiol"},{"key":"10.1016\/j.vaccine.2017.07.082_b0060","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1016\/j.vaccine.2005.12.024","article-title":"Rapid, high-level production of hepatitis B core antigen in plant leaf and its immunogenicity in mice","volume":"24","author":"Huang","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.07.082_b0065","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1002\/bit.22299","article-title":"A DNA replicon system for rapid high-level production of virus-like particles in plants","volume":"103","author":"Huang","year":"2009","journal-title":"Biotechnol Bioeng"},{"key":"10.1016\/j.vaccine.2017.07.082_b0070","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1046\/j.1423-0410.1998.7430148.x","article-title":"Application of the human hepatitis B virus core antigen from transgenic tobacco plants for serological diagnosis","volume":"74","author":"Tsuda","year":"1998","journal-title":"Vox Sang"},{"key":"10.1016\/j.vaccine.2017.07.082_b0075","unstructured":"Pniewski T, Kapusta J, P\u0142ucienniczak A, P\u0142ucienniczak G, Boci\u0105g P, Kostrzak A, et al. Transgenic plant cells producing antigenic protein HBcAg and their application in production of vaccine. Patent No. 216099; 2013 [in Polish]."},{"key":"10.1016\/j.vaccine.2017.07.082_b0080","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1007\/BF00028908","article-title":"New plant binary vectors with selectable markers located proximal to the left T-DNA border","volume":"20","author":"Becker","year":"1992","journal-title":"Plant Mol Biol"},{"key":"10.1016\/j.vaccine.2017.07.082_b0085","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s00299-011-1223-7","article-title":"Plant expression, lyophilisation and storage of HBV medium and large surface antigens for a prototype oral vaccine formulation","volume":"31","author":"Pniewski","year":"2012","journal-title":"Plant Cell Rep"},{"key":"10.1016\/j.vaccine.2017.07.082_b0090","series-title":"Biological electron microscopy: theory, techniques, and troubleshooting","author":"Dykstra","year":"2003"},{"key":"10.1016\/j.vaccine.2017.07.082_b0095","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1073\/pnas.79.5.1606","article-title":"Hepatitis B virus core antigen: synthesis in Escherichia coli and application in diagnosis","volume":"79","author":"Stahl","year":"1982","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2017.07.082_b0100","doi-asserted-by":"crossref","first-page":"3319","DOI":"10.1128\/JVI.64.7.3319-3330.1990","article-title":"Hepatitis B virus nucleocapsid assembly: primary structure requirements in the core protein","volume":"64","author":"Birnbaum","year":"1990","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2017.07.082_b0105","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jviromet.2015.09.005","article-title":"A protocol for the gentle purification of virus-like particles produced in plants","volume":"225","author":"Peyret","year":"2015","journal-title":"J Virol Meth"},{"key":"10.1016\/j.vaccine.2017.07.082_b0110","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.virol.2012.09.014","article-title":"A molecular assembly system for presentation of antigens on the surface of HBc virus-like particles","volume":"435","author":"Blokhina","year":"2013","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2017.07.082_b0115","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1159\/000360947","article-title":"Genotypes and genetic variability of hepatitis B virus","volume":"57","author":"Kramvis","year":"2014","journal-title":"Intervirology"},{"key":"10.1016\/j.vaccine.2017.07.082_b0120","doi-asserted-by":"crossref","unstructured":"Sunbul M. Hepatitis B virus genotypes: Global distribution and clinical importance 2014;20: 5427\u201334. doi:10.3748\/wjg.v20.i18.5427.","DOI":"10.3748\/wjg.v20.i18.5427"},{"key":"10.1016\/j.vaccine.2017.07.082_b0125","doi-asserted-by":"crossref","first-page":"289","DOI":"10.4254\/wjh.v7.i3.289","article-title":"Genotypes and viral variants in chronic hepatitis B: a review of epidemiology and clinical relevance","volume":"7","author":"Croagh","year":"2015","journal-title":"World J Hepatol"},{"key":"10.1016\/j.vaccine.2017.07.082_b0130","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1159\/000067922","article-title":"Generation of recombinant virus-like particles of human and non-human polyomaviruses in yeast Saccharomyces cerevisiae","volume":"45","author":"Sasnauskas","year":"2003","journal-title":"Intervirology"},{"key":"10.1016\/j.vaccine.2017.07.082_b0135","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1002\/(SICI)1096-9071(200004)60:4<475::AID-JMV17>3.0.CO;2-B","article-title":"Expression of recombinant Norwalk-like virus capsid proteins using a bacterial system and the development of its immunologic detection","volume":"60","author":"Yoda","year":"2000","journal-title":"J Med Virol"},{"key":"10.1016\/j.vaccine.2017.07.082_b0140","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s705-002-8306-5","article-title":"Baculovirus expression and antigenic characterization of the capsid proteins of three Norwalk-like viruses","volume":"147","author":"Jiang","year":"2002","journal-title":"Arch Virol"},{"key":"10.1016\/j.vaccine.2017.07.082_b0145","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S1360-1385(01)01922-7","article-title":"Medical molecular farming: production of antibodies, biopharmaceuticals and edible vaccines in plants","volume":"6","author":"Daniell","year":"2001","journal-title":"Trends Plant Sci"},{"key":"10.1016\/j.vaccine.2017.07.082_b0150","doi-asserted-by":"crossref","unstructured":"Sainsbury F, Lavoie PO, D\u2019Aoust MA, V\u00e9zina LP, Lomonossoff GP. Expression of multiple proteins using full-length and deleted versions of cowpea mosaic virus RNA-2. Plant Biotechnol J 2008;6:82\u201392. doi:10.1111\/j.1467-7652.2007.00303.x.","DOI":"10.1111\/j.1467-7652.2007.00303.x"},{"key":"10.1016\/j.vaccine.2017.07.082_b0155","doi-asserted-by":"crossref","first-page":"785382","DOI":"10.1155\/2014\/785382","article-title":"Plant virus expression vector development: new perspectives","volume":"2014","author":"Hefferon","year":"2014","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.vaccine.2017.07.082_b0160","doi-asserted-by":"crossref","first-page":"26","DOI":"10.4161\/hv.22218","article-title":"Plant-derived virus-like particles as vaccines","volume":"9","author":"Chen","year":"2013","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2017.07.082_b0165","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1128\/JVI.63.2.798-808.1989","article-title":"Antigenic determinants and functional domains in core antigen and e antigen from hepatitis B virus","volume":"63","author":"Salfeld","year":"1989","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2017.07.082_b0170","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1128\/CDLI.2.6.726-732.1995","article-title":"Selective increases in antibody isotypes and immunoglobulin G subclass responses to secreted antigens in tuberculosis patients and healthy household contacts of the patients","volume":"2","author":"Hussain","year":"1995","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.vaccine.2017.07.082_b0175","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0304-3940(02)01357-5","article-title":"Importance of IgG2c isotype in the immune response to ??-amyloid in amyloid precursor protein\/transgenic mice","volume":"338","author":"Petrushina","year":"2003","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.vaccine.2017.07.082_b0180","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.molimm.2014.06.010","article-title":"How antibodies use complement to regulate antibody responses","volume":"61","author":"S\u00f6rman","year":"2014","journal-title":"Mol Immunol"},{"key":"10.1016\/j.vaccine.2017.07.082_b0185","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1128\/JVI.76.1.432-435.2002","article-title":"Increased efficacy of the immunoglobulin G2a subclass in antibody-mediated protection against lactate dehydrogenase-elevating virus-induced polioencephalomyelitis revealed with switch mutants","volume":"76","author":"Markine-Goriaynoff","year":"2002","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2017.07.082_b0190","first-page":"817580","article-title":"Therapeutic vaccination in chronic hepatitis B: preclinical studies in the woodchuck","volume":"2010","author":"Kosinska","year":"2010","journal-title":"Hepat Res Treat"},{"key":"10.1016\/j.vaccine.2017.07.082_b0195","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.ijid.2006.09.010","article-title":"Phase I clinical trial in healthy adults of a nasal vaccine candidate containing recombinant hepatitis B surface and core antigens","volume":"11","author":"Betancourt","year":"2007","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.vaccine.2017.07.082_b0200","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.2174\/138920112804724837","article-title":"Is an oral plant-based vaccine against hepatitis B virus possible?","volume":"13","author":"Pniewski","year":"2012","journal-title":"Curr Pharm Biotechnol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17310083?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17310083?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,17]],"date-time":"2020-10-17T16:36:53Z","timestamp":1602952613000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X17310083"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":40,"journal-issue":{"issue":"42","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["S0264410X17310083"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.07.082","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HBcAg produced in transgenic tobacco triggers Th1 and Th2 response when intramuscularly delivered","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.07.082","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}